Register Login

ASHLAND INC. (ASH)

SymbolASH
NameASHLAND INC.
SectorCONSUMER DISCRETIONARY
RegionNorth America
IndustrySpecialty Chemicals
Address8145 BLAZER DRIVE, WILMINGTON, Delaware, 19808, United States
Telephone+1 302 995-3000
Fax—
Email—
Websitehttp://www.ashland.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001674862
Description

Ashland Global Holdings is a global specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into five distinct segments: life sciences, personal care and household, performance adhesives, specialty additives, and intermediates and solvents. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. There is not a single segment that represents a majority of revenue given its extensive portfolio of products. A large portion of revenue is generated outside of the United States and there is higher demand for the companys services during warmer weather months.

Additional info from NASDAQ:
Ashland Global Holdings is a global specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into five distinct segments: life sciences, personal care and household, performance adhesives, specialty additives, and intermediates and solvents. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. There is not a single segment that represents a majority of revenue given its extensive portfolio of products. A large portion of revenue is generated outside of the United States and there is higher demand for the companys services during warmer weather months.

2026-08-31 22:30

Ashland to host Innovation Day for analysts and investors

Read more
2026-08-24 11:00

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Read more
2026-08-12 20:30

LAMPKIN ROBIN E. 🟡 adjusted position in 3.1K shares (1 derivative) of ASHLAND INC. (ASH) at $74.58 Transaction Date: Aug 11, 2026 | Filing ID: 346960

Read more
2026-08-12 18:01

New Form SCHEDULE 13G/A - ASHLAND INC. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000912938-26-000785 <b>Size:</b> 6 KB

Read more
2026-08-07 21:00

Ashland board authorizes quarterly dividend

Read more
2026-07-31 20:30

(99% Neutral) ASHLAND INC. (ASH) Announces Business Combination

Read more
2026-07-31 12:21

New Form SCHEDULE 13G - ASHLAND INC. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100121-26-000893 <b>Size:</b> 7 KB

Read more
2026-07-30 20:30

MUSA OSAMA M 🟡 adjusted position in 8.5K shares (1 derivative) of ASHLAND INC. (ASH) at $57.96 Transaction Date: Jul 29, 2026 | Filing ID: 326228

Read more
2026-07-29 20:30

Assis Alessandra Faccin 🟡 adjusted position in 884 shares (1 derivative) of ASHLAND INC. (ASH) at $66.38 Transaction Date: Jul 27, 2026 | Filing ID: 323842

Read more
2026-07-28 21:12

(10% Negative) ASHLAND INC. (ASH) Announces Business Combination

Read more